156 related articles for article (PubMed ID: 12077884)
1. [What kind of new drugs will we get in the future and why?].
Lammintausta R
Duodecim; 2000; 116(24):2807-8. PubMed ID: 12077884
[No Abstract] [Full Text] [Related]
2. Drug Discovery Technology and Development 2005 - IBC's Tenth World Congress. Emerging and early stage company showcase pre-conference symposium.
Razvi ES
IDrugs; 2005 Oct; 8(10):796-8. PubMed ID: 16254794
[No Abstract] [Full Text] [Related]
3. Impact of the new biologies on the medical and pharmaceutical sciences.
Tomlinson E
J Pharm Pharmacol; 1992 Feb; 44 Suppl 1():147-59. PubMed ID: 1348276
[No Abstract] [Full Text] [Related]
4. CombinatoRx brings its molecular speed dating to Singapore.
Frank MG; Altmeyer R
Biotechnol J; 2007 Nov; 2(11):1325-6. PubMed ID: 17939128
[No Abstract] [Full Text] [Related]
5. [Does the search for new drugs still make sense?].
Joly P
Bull Acad Natl Med; 1986 Dec; 170(9):1143-53. PubMed ID: 3300868
[No Abstract] [Full Text] [Related]
6. Drug discovery and natural products: end of an era or an endless frontier?
Li JW; Vederas JC
Science; 2009 Jul; 325(5937):161-5. PubMed ID: 19589993
[TBL] [Abstract][Full Text] [Related]
7. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
8. Rediscovering plant-based drugs.
Littleton J; Falcone D; Davies HM
Nat Biotechnol; 2003 Aug; 21(8):843-4. PubMed ID: 12894188
[No Abstract] [Full Text] [Related]
9. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
10. [News in pharmaceutics].
Arch Pediatr; 2013 Dec; 20(12):1380-4. PubMed ID: 24404599
[No Abstract] [Full Text] [Related]
11. Timely synthetic support for medicinal chemists.
Potoski J
Drug Discov Today; 2005 Jan; 10(2):115-20. PubMed ID: 15718160
[TBL] [Abstract][Full Text] [Related]
12. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
Federsel HJ
Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
[TBL] [Abstract][Full Text] [Related]
13. Implications of pharmacogenomics for drug development and clinical practice.
Ginsburg GS; Konstance RP; Allsbrook JS; Schulman KA
Arch Intern Med; 2005 Nov; 165(20):2331-6. PubMed ID: 16287761
[TBL] [Abstract][Full Text] [Related]
14. The pharmaceutical industry in the Arab world: challenges, controversies, and future outlook.
Kandil O
Drug Discov Today; 2004 Jul; 9(13):543-5. PubMed ID: 15203084
[No Abstract] [Full Text] [Related]
15. Antibacterial drug discovery: is small pharma the solution?
Boggs AF; Miller GH
Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():32-6. PubMed ID: 15522038
[TBL] [Abstract][Full Text] [Related]
16. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
17. A decade of fragment-based drug design: strategic advances and lessons learned.
Hajduk PJ; Greer J
Nat Rev Drug Discov; 2007 Mar; 6(3):211-9. PubMed ID: 17290284
[TBL] [Abstract][Full Text] [Related]
18. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
19. Drug Discovery Technology Europe 2005 - IBC's Ninth Annual Conference and Exhibition.
Austin S
IDrugs; 2005 May; 8(5):370-3. PubMed ID: 15883912
[No Abstract] [Full Text] [Related]
20. Surviving the blockbuster syndrome.
Service RF
Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
